Corporate News 11-Feb-22
Alkem signs license agreement with Harvard University's Office of Technology Development
Alkem Laboratories has signed a license agreement with Harvard University's Office of Technology Development (OTD) enabling Alkem to develop and commercialize a novel technology that may help meet the dire need for effective treatment of diabetic neuropathy, foot ulcers, peripheral arterial disease (PAD), and other injuries caused by vascular disease. The license grants Alkem commercialization rights in the United States and India.
Previous News
Sensex, Nifty end at record closing highs, Nifty Bank hits all-time high
( Market Commentary - Quick Review 25-Jun-24 15:43 )
Indices trade with major gains; financial services edge higher
( Market Commentary - Mid-Session 25-Jun-24 14:32 )
Alkem Labs PAT soars 90% YoY to Rs 545 crore in Q1
( Hot Pursuit - 09-Aug-24 14:30 )
Alkem Laboratories Ltd spurts 2.93%, up for fifth straight session
( Hot Pursuit - 30-Aug-24 13:00 )
Volumes soar at J K Cements Ltd counter
( Hot Pursuit - 06-Nov-23 11:00 )
Alkem Laboratories
( Results - Analysis 04-Feb-22 15:40 )
Alkem Labs tanks on buzz of tax evasion
( Hot Pursuit - 26-Feb-24 14:25 )
Alkem Laboratories Ltd spurts 1.54%, up for five straight sessions
( Hot Pursuit - 02-Nov-23 13:00 )
Zydus Lifesciences Ltd Slides 1.88%
( Hot Pursuit - 18-Jun-24 09:30 )
Volumes spurt at Alkem Laboratories Ltd counter
( Hot Pursuit - 26-Feb-24 14:30 )
Alkem Laboratories consolidated net profit rises 90.13% in the June 2024 quarter
( Results - Announcements 09-Aug-24 13:48 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top
